These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 15982353

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Anti-oxidative properties of beta-blockers and angiotensin-converting enzyme inhibitors in congestive heart failure.
    Chin BS, Langford NJ, Nuttall SL, Gibbs CR, Blann AD, Lip GY.
    Eur J Heart Fail; 2003 Mar; 5(2):171-4. PubMed ID: 12644008
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Endothelial function and dysfunction in heart failure.
    Ferrari R, Bachetti T, Agnoletti L, Comini L, Curello S.
    Eur Heart J; 1998 Jul; 19 Suppl G():G41-7. PubMed ID: 9717055
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Prospects of endothelial dysfunction reversion in patients with congestive heart failure].
    Vizir VA, Berezin AE.
    Klin Med (Mosk); 2000 Jul; 78(7):36-9. PubMed ID: 10979640
    [Abstract] [Full Text] [Related]

  • 11. Bradykinin contributes to the systemic hemodynamic effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure.
    Cruden NL, Witherow FN, Webb DJ, Fox KA, Newby DE.
    Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1043-8. PubMed ID: 15105283
    [Abstract] [Full Text] [Related]

  • 12. Association of genetic polymorphisms with endothelial dysfunction in chronic heart failure.
    Kose M, Akpinar TS, Bakkaloglu OK, Tufan A, Sumnu A, Emet S, Kocaaga M, Erk O, Kayacan MS, Güler K, Demirel AS.
    Eur Rev Med Pharmacol Sci; 2014 Jun; 18(12):1755-61. PubMed ID: 24992619
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Abnormalities of hemorheological, endothelial, and platelet function in patients with chronic heart failure in sinus rhythm: effects of angiotensin-converting enzyme inhibitor and beta-blocker therapy.
    Gibbs CR, Blann AD, Watson RD, Lip GY.
    Circulation; 2001 Apr 03; 103(13):1746-51. PubMed ID: 11282905
    [Abstract] [Full Text] [Related]

  • 16. Endothelial dysfunction and damage in congestive heart failure: relation of flow-mediated dilation to circulating endothelial cells, plasma indexes of endothelial damage, and brain natriuretic peptide.
    Chong AY, Blann AD, Patel J, Freestone B, Hughes E, Lip GY.
    Circulation; 2004 Sep 28; 110(13):1794-8. PubMed ID: 15364797
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. ADEPT: Addition of the AT1 receptor antagonist eprosartan to ACE inhibitor therapy in chronic heart failure trial: hemodynamic and neurohormonal effects.
    Murdoch DR, McDonagh TA, Farmer R, Morton JJ, McMurray JJ, Dargie HJ.
    Am Heart J; 2001 May 28; 141(5):800-7. PubMed ID: 11320369
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.